Zacks Research Issues Negative Outlook for RDY Earnings
Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) – Equities research analysts at Zacks Research lowered their Q1 2026 earnings estimates for shares of Dr. Reddy’s Laboratories in a report issued on Thursday, February 6th. Zacks Research analyst R. Department now anticipates that the company will earn $0.19 per share for the quarter, down from […]
![Zacks Research Issues Negative Outlook for RDY Earnings](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/dr-reddys-laboratories-limited-logo-1200x675.png?v=20240202075321&w=240&h=240&zc=2)